Compounded products are not FDA-approved and are not intended to diagnose, treat, cure, or prevent any disease
These results are not typical
They're addressing different aspects of the same underlying biology in many patients, and a thoughtful coordinated plan tends to produce better results than either medication alone
Patients Seeking Sustained, Proven Efficacy: With 72-week and 3-year data available from SURMOUNT-1, Tirzepatide offers a well-established track record of sustained results
During this early phase, your provider may assess tolerability, response, and whether any adjustments are appropriate
However, some groups may need closer attention: Older adults : The risk of OH is higher due to age-related changes in blood pressure control